| |
| |
|
| Insider
Information: |
Aker Christopher Ray |
| Relationship: |
Sr. VP & General Counsel |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
10,056 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$22,224 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
10,056 |
|
|
| Total
Value |
$22,224 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regulus Therapeutics Inc. |
RGLS |
Sr. VP & General Counsel |
2024-01-18 |
10,056 |
2019-02-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGLS |
Regulus Therapeutics Inc. |
Sr. VP & General Counsel |
• – – |
2024-01-18 |
4 |
AS |
$1.19 |
$6,510 |
D/D |
(5,468) |
10,056 |
0 |
% |
|
| RGLS |
Regulus Therapeutics Inc. |
Sr. VP & General Counsel |
• – – |
2024-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,250 |
15,524 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Sr. VP & General Counsel |
• – – |
2021-05-17 |
4 |
AS |
$0.89 |
$765 |
D/D |
(860) |
41,754 |
0 |
% |
|
| RGLS |
Regulus Therapeutics Inc. |
Sr. VP & General Counsel |
• – – |
2021-02-16 |
4 |
AS |
$1.72 |
$1,424 |
D/D |
(828) |
42,614 |
0 |
% |
|
| RGLS |
Regulus Therapeutics Inc. |
Sr. VP & General Counsel |
• – – |
2020-11-16 |
4 |
AS |
$0.52 |
$456 |
D/D |
(876) |
25,762 |
0 |
% |
|
| RGLS |
Regulus Therapeutics Inc. |
Sr. VP & General Counsel |
• – – |
2020-08-14 |
4 |
AS |
$0.61 |
$528 |
D/D |
(872) |
26,638 |
0 |
% |
|
| RGLS |
Regulus Therapeutics Inc. |
Sr. VP & General Counsel |
• – – |
2020-05-15 |
4 |
AS |
$0.63 |
$570 |
D/D |
(909) |
27,510 |
0 |
% |
|
| RGLS |
Regulus Therapeutics Inc. |
Sr. VP & General Counsel |
• – – |
2020-02-18 |
4 |
AS |
$0.83 |
$737 |
D/D |
(888) |
28,419 |
0 |
% |
|
| RGLS |
Regulus Therapeutics Inc. |
Sr. VP & General Counsel |
• – – |
2020-01-02 |
4 |
AS |
$0.97 |
$2,164 |
D/D |
(2,239) |
29,307 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Sr. VP & General Counsel |
• – – |
2019-10-01 |
4 |
AS |
$0.68 |
$1,602 |
D/D |
(2,346) |
32,379 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Sr. VP & General Counsel |
• – – |
2019-08-15 |
4 |
AS |
$0.55 |
$495 |
D/D |
(899) |
34,725 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Sr. VP & General Counsel |
• – – |
2019-07-01 |
4 |
AS |
$1.31 |
$2,918 |
D/D |
(2,225) |
35,624 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Sr. VP & General Counsel |
• – – |
2019-05-15 |
4 |
AS |
$1.41 |
$9,796 |
D/D |
(6,950) |
59,309 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Sr. VP & General Counsel |
• – – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
38,512 |
66,259 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Sr. VP & General Counsel |
• – – |
2019-04-01 |
4 |
AS |
$0.98 |
$2,659 |
D/D |
(2,710) |
6,287 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
Sr. VP & General Counsel |
• – – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
27,747 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
